ÂÜÀòÂÒÂ×

Kasper Veje is an accomplished professional with extensive experience in the pharmaceutical industry, currently serving as Vice President, Head of Diabetes & Obesity Search and Evaluation at Novo Nordisk since February 2024. Previously, Kasper held the position of Vice President, Commercial Strategy, Business Development, and Alliance Management at Corium, Inc. from May 2022 to December 2023. During a notable tenure at Novo Nordisk from 2011 to 2022, Kasper progressed through several leadership roles, including Executive Director, where responsibilities included overseeing commercial execution for a sales force generating approximately $8 billion in net sales, along with managing the $3 billion insulin portfolio. Earlier roles included Director of Investor Relations, where Kasper achieved recognition as a top-ranked US investor relations officer, and Project Manager focused on sustainable business models for diabetes care. Educational qualifications include a MSc in International Marketing and Management from Copenhagen Business School, an Executive Program in Leadership from Stanford University, and a BSc in Business Administration and Philosophy from Copenhagen Business School.